ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bispecific and Trispecific Antibody Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-24C10334
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bispecific and Trispecific Antibody Market Research Report 2022
BUY CHAPTERS

Global Bispecific and Trispecific Antibody Market Research Report 2025

Code: QYRE-Auto-24C10334
Report
March 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Affimed NV
BioNTech
Genmab
MacroGenics Inc
Sanofi
Roche
Amgen Inc
Pfizer Inc
Johnson & Johnson
Astrazeneca plc
Biotheus
GT Biopharma
Harpoon Therapeutics
Numab
Sichuan Baili Pharmaceuticals

Bispecific and Trispecific Antibody Market

The global market for Bispecific and Trispecific Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Bispecific and Trispecific Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bispecific and Trispecific Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Bispecific and Trispecific Antibody in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Bispecific and Trispecific Antibody include AbbVie, Affimed, Biotheus, Biontech, Genmab, GT Biopharma, Harpoon Therapeutics, MacroGenics, Numab, Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bispecific and Trispecific Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific and Trispecific Antibody.
The Bispecific and Trispecific Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bispecific and Trispecific Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific and Trispecific Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Bispecific and Trispecific Antibody Market Report

Report Metric Details
Report Name Bispecific and Trispecific Antibody Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Affimed, Biotheus, Biontech, Genmab, GT Biopharma, Harpoon Therapeutics, MacroGenics, Numab, Sanofi, Sichuan Baili Pharmaceuticals, Roche, Amgen, Pfizer, Johnson & Johnson, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Bispecific and Trispecific Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bispecific and Trispecific Antibody Market report?

Ans: The main players in the Bispecific and Trispecific Antibody Market are AbbVie, Affimed, Biotheus, Biontech, Genmab, GT Biopharma, Harpoon Therapeutics, MacroGenics, Numab, Sanofi, Sichuan Baili Pharmaceuticals, Roche, Amgen, Pfizer, Johnson & Johnson, AstraZeneca

What are the Application segmentation covered in the Bispecific and Trispecific Antibody Market report?

Ans: The Applications covered in the Bispecific and Trispecific Antibody Market report are Cancer, Haemophilia, Others

What are the Type segmentation covered in the Bispecific and Trispecific Antibody Market report?

Ans: The Types covered in the Bispecific and Trispecific Antibody Market report are Bispecific Antibody, Trispecific Antibody

Recommended Reports

Antibody Drug Markets

Oncology Biosimilars

Cancer Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bispecific and Trispecific Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bispecific Antibody
1.2.3 Trispecific Antibody
1.3 Market by Application
1.3.1 Global Bispecific and Trispecific Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bispecific and Trispecific Antibody Market Perspective (2020-2031)
2.2 Global Bispecific and Trispecific Antibody Growth Trends by Region
2.2.1 Global Bispecific and Trispecific Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bispecific and Trispecific Antibody Historic Market Size by Region (2020-2025)
2.2.3 Bispecific and Trispecific Antibody Forecasted Market Size by Region (2026-2031)
2.3 Bispecific and Trispecific Antibody Market Dynamics
2.3.1 Bispecific and Trispecific Antibody Industry Trends
2.3.2 Bispecific and Trispecific Antibody Market Drivers
2.3.3 Bispecific and Trispecific Antibody Market Challenges
2.3.4 Bispecific and Trispecific Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bispecific and Trispecific Antibody Players by Revenue
3.1.1 Global Top Bispecific and Trispecific Antibody Players by Revenue (2020-2025)
3.1.2 Global Bispecific and Trispecific Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Bispecific and Trispecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bispecific and Trispecific Antibody Revenue
3.4 Global Bispecific and Trispecific Antibody Market Concentration Ratio
3.4.1 Global Bispecific and Trispecific Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bispecific and Trispecific Antibody Revenue in 2024
3.5 Global Key Players of Bispecific and Trispecific Antibody Head office and Area Served
3.6 Global Key Players of Bispecific and Trispecific Antibody, Product and Application
3.7 Global Key Players of Bispecific and Trispecific Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bispecific and Trispecific Antibody Breakdown Data by Type
4.1 Global Bispecific and Trispecific Antibody Historic Market Size by Type (2020-2025)
4.2 Global Bispecific and Trispecific Antibody Forecasted Market Size by Type (2026-2031)
5 Bispecific and Trispecific Antibody Breakdown Data by Application
5.1 Global Bispecific and Trispecific Antibody Historic Market Size by Application (2020-2025)
5.2 Global Bispecific and Trispecific Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bispecific and Trispecific Antibody Market Size (2020-2031)
6.2 North America Bispecific and Trispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bispecific and Trispecific Antibody Market Size by Country (2020-2025)
6.4 North America Bispecific and Trispecific Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bispecific and Trispecific Antibody Market Size (2020-2031)
7.2 Europe Bispecific and Trispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bispecific and Trispecific Antibody Market Size by Country (2020-2025)
7.4 Europe Bispecific and Trispecific Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bispecific and Trispecific Antibody Market Size (2020-2031)
8.2 Asia-Pacific Bispecific and Trispecific Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bispecific and Trispecific Antibody Market Size (2020-2031)
9.2 Latin America Bispecific and Trispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bispecific and Trispecific Antibody Market Size by Country (2020-2025)
9.4 Latin America Bispecific and Trispecific Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bispecific and Trispecific Antibody Market Size (2020-2031)
10.2 Middle East & Africa Bispecific and Trispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Bispecific and Trispecific Antibody Introduction
11.1.4 AbbVie Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Affimed
11.2.1 Affimed Company Details
11.2.2 Affimed Business Overview
11.2.3 Affimed Bispecific and Trispecific Antibody Introduction
11.2.4 Affimed Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.2.5 Affimed Recent Development
11.3 Biotheus
11.3.1 Biotheus Company Details
11.3.2 Biotheus Business Overview
11.3.3 Biotheus Bispecific and Trispecific Antibody Introduction
11.3.4 Biotheus Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.3.5 Biotheus Recent Development
11.4 Biontech
11.4.1 Biontech Company Details
11.4.2 Biontech Business Overview
11.4.3 Biontech Bispecific and Trispecific Antibody Introduction
11.4.4 Biontech Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.4.5 Biontech Recent Development
11.5 Genmab
11.5.1 Genmab Company Details
11.5.2 Genmab Business Overview
11.5.3 Genmab Bispecific and Trispecific Antibody Introduction
11.5.4 Genmab Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.5.5 Genmab Recent Development
11.6 GT Biopharma
11.6.1 GT Biopharma Company Details
11.6.2 GT Biopharma Business Overview
11.6.3 GT Biopharma Bispecific and Trispecific Antibody Introduction
11.6.4 GT Biopharma Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.6.5 GT Biopharma Recent Development
11.7 Harpoon Therapeutics
11.7.1 Harpoon Therapeutics Company Details
11.7.2 Harpoon Therapeutics Business Overview
11.7.3 Harpoon Therapeutics Bispecific and Trispecific Antibody Introduction
11.7.4 Harpoon Therapeutics Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.7.5 Harpoon Therapeutics Recent Development
11.8 MacroGenics
11.8.1 MacroGenics Company Details
11.8.2 MacroGenics Business Overview
11.8.3 MacroGenics Bispecific and Trispecific Antibody Introduction
11.8.4 MacroGenics Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.8.5 MacroGenics Recent Development
11.9 Numab
11.9.1 Numab Company Details
11.9.2 Numab Business Overview
11.9.3 Numab Bispecific and Trispecific Antibody Introduction
11.9.4 Numab Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.9.5 Numab Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Bispecific and Trispecific Antibody Introduction
11.10.4 Sanofi Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Sichuan Baili Pharmaceuticals
11.11.1 Sichuan Baili Pharmaceuticals Company Details
11.11.2 Sichuan Baili Pharmaceuticals Business Overview
11.11.3 Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Introduction
11.11.4 Sichuan Baili Pharmaceuticals Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.11.5 Sichuan Baili Pharmaceuticals Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Bispecific and Trispecific Antibody Introduction
11.12.4 Roche Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.12.5 Roche Recent Development
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Bispecific and Trispecific Antibody Introduction
11.13.4 Amgen Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.13.5 Amgen Recent Development
11.14 Pfizer
11.14.1 Pfizer Company Details
11.14.2 Pfizer Business Overview
11.14.3 Pfizer Bispecific and Trispecific Antibody Introduction
11.14.4 Pfizer Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.14.5 Pfizer Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Bispecific and Trispecific Antibody Introduction
11.15.4 Johnson & Johnson Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.15.5 Johnson & Johnson Recent Development
11.16 AstraZeneca
11.16.1 AstraZeneca Company Details
11.16.2 AstraZeneca Business Overview
11.16.3 AstraZeneca Bispecific and Trispecific Antibody Introduction
11.16.4 AstraZeneca Revenue in Bispecific and Trispecific Antibody Business (2020-2025)
11.16.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Affimed NV
BioNTech
Genmab
MacroGenics Inc
Sanofi
Roche
Amgen Inc
Pfizer Inc
Johnson & Johnson
Astrazeneca plc
Biotheus
GT Biopharma
Harpoon Therapeutics
Numab
Sichuan Baili Pharmaceuticals
List of Tables
 Table 1. Global Bispecific and Trispecific Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Bispecific Antibody
 Table 3. Key Players of Trispecific Antibody
 Table 4. Global Bispecific and Trispecific Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Bispecific and Trispecific Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Bispecific and Trispecific Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Bispecific and Trispecific Antibody Market Share by Region (2020-2025)
 Table 8. Global Bispecific and Trispecific Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Bispecific and Trispecific Antibody Market Share by Region (2026-2031)
 Table 10. Bispecific and Trispecific Antibody Market Trends
 Table 11. Bispecific and Trispecific Antibody Market Drivers
 Table 12. Bispecific and Trispecific Antibody Market Challenges
 Table 13. Bispecific and Trispecific Antibody Market Restraints
 Table 14. Global Bispecific and Trispecific Antibody Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Bispecific and Trispecific Antibody Market Share by Players (2020-2025)
 Table 16. Global Top Bispecific and Trispecific Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific and Trispecific Antibody as of 2024)
 Table 17. Ranking of Global Top Bispecific and Trispecific Antibody Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Bispecific and Trispecific Antibody Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Bispecific and Trispecific Antibody, Headquarters and Area Served
 Table 20. Global Key Players of Bispecific and Trispecific Antibody, Product and Application
 Table 21. Global Key Players of Bispecific and Trispecific Antibody, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Bispecific and Trispecific Antibody Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Bispecific and Trispecific Antibody Revenue Market Share by Type (2020-2025)
 Table 25. Global Bispecific and Trispecific Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Bispecific and Trispecific Antibody Revenue Market Share by Type (2026-2031)
 Table 27. Global Bispecific and Trispecific Antibody Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Bispecific and Trispecific Antibody Revenue Market Share by Application (2020-2025)
 Table 29. Global Bispecific and Trispecific Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Bispecific and Trispecific Antibody Revenue Market Share by Application (2026-2031)
 Table 31. North America Bispecific and Trispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Bispecific and Trispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Bispecific and Trispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Bispecific and Trispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Bispecific and Trispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Bispecific and Trispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Bispecific and Trispecific Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Bispecific and Trispecific Antibody Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Bispecific and Trispecific Antibody Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bispecific and Trispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Bispecific and Trispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Bispecific and Trispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Bispecific and Trispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Bispecific and Trispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Bispecific and Trispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AbbVie Company Details
 Table 47. AbbVie Business Overview
 Table 48. AbbVie Bispecific and Trispecific Antibody Product
 Table 49. AbbVie Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 50. AbbVie Recent Development
 Table 51. Affimed Company Details
 Table 52. Affimed Business Overview
 Table 53. Affimed Bispecific and Trispecific Antibody Product
 Table 54. Affimed Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 55. Affimed Recent Development
 Table 56. Biotheus Company Details
 Table 57. Biotheus Business Overview
 Table 58. Biotheus Bispecific and Trispecific Antibody Product
 Table 59. Biotheus Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 60. Biotheus Recent Development
 Table 61. Biontech Company Details
 Table 62. Biontech Business Overview
 Table 63. Biontech Bispecific and Trispecific Antibody Product
 Table 64. Biontech Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 65. Biontech Recent Development
 Table 66. Genmab Company Details
 Table 67. Genmab Business Overview
 Table 68. Genmab Bispecific and Trispecific Antibody Product
 Table 69. Genmab Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 70. Genmab Recent Development
 Table 71. GT Biopharma Company Details
 Table 72. GT Biopharma Business Overview
 Table 73. GT Biopharma Bispecific and Trispecific Antibody Product
 Table 74. GT Biopharma Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 75. GT Biopharma Recent Development
 Table 76. Harpoon Therapeutics Company Details
 Table 77. Harpoon Therapeutics Business Overview
 Table 78. Harpoon Therapeutics Bispecific and Trispecific Antibody Product
 Table 79. Harpoon Therapeutics Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 80. Harpoon Therapeutics Recent Development
 Table 81. MacroGenics Company Details
 Table 82. MacroGenics Business Overview
 Table 83. MacroGenics Bispecific and Trispecific Antibody Product
 Table 84. MacroGenics Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 85. MacroGenics Recent Development
 Table 86. Numab Company Details
 Table 87. Numab Business Overview
 Table 88. Numab Bispecific and Trispecific Antibody Product
 Table 89. Numab Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 90. Numab Recent Development
 Table 91. Sanofi Company Details
 Table 92. Sanofi Business Overview
 Table 93. Sanofi Bispecific and Trispecific Antibody Product
 Table 94. Sanofi Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 95. Sanofi Recent Development
 Table 96. Sichuan Baili Pharmaceuticals Company Details
 Table 97. Sichuan Baili Pharmaceuticals Business Overview
 Table 98. Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Product
 Table 99. Sichuan Baili Pharmaceuticals Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 100. Sichuan Baili Pharmaceuticals Recent Development
 Table 101. Roche Company Details
 Table 102. Roche Business Overview
 Table 103. Roche Bispecific and Trispecific Antibody Product
 Table 104. Roche Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 105. Roche Recent Development
 Table 106. Amgen Company Details
 Table 107. Amgen Business Overview
 Table 108. Amgen Bispecific and Trispecific Antibody Product
 Table 109. Amgen Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 110. Amgen Recent Development
 Table 111. Pfizer Company Details
 Table 112. Pfizer Business Overview
 Table 113. Pfizer Bispecific and Trispecific Antibody Product
 Table 114. Pfizer Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 115. Pfizer Recent Development
 Table 116. Johnson & Johnson Company Details
 Table 117. Johnson & Johnson Business Overview
 Table 118. Johnson & Johnson Bispecific and Trispecific Antibody Product
 Table 119. Johnson & Johnson Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 120. Johnson & Johnson Recent Development
 Table 121. AstraZeneca Company Details
 Table 122. AstraZeneca Business Overview
 Table 123. AstraZeneca Bispecific and Trispecific Antibody Product
 Table 124. AstraZeneca Revenue in Bispecific and Trispecific Antibody Business (2020-2025) & (US$ Million)
 Table 125. AstraZeneca Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Bispecific and Trispecific Antibody Picture
 Figure 2. Global Bispecific and Trispecific Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bispecific and Trispecific Antibody Market Share by Type: 2024 VS 2031
 Figure 4. Bispecific Antibody Features
 Figure 5. Trispecific Antibody Features
 Figure 6. Global Bispecific and Trispecific Antibody Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bispecific and Trispecific Antibody Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Case Studies
 Figure 9. Haemophilia Case Studies
 Figure 10. Others Case Studies
 Figure 11. Bispecific and Trispecific Antibody Report Years Considered
 Figure 12. Global Bispecific and Trispecific Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Bispecific and Trispecific Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Bispecific and Trispecific Antibody Market Share by Region: 2024 VS 2031
 Figure 15. Global Bispecific and Trispecific Antibody Market Share by Players in 2024
 Figure 16. Global Top Bispecific and Trispecific Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific and Trispecific Antibody as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Bispecific and Trispecific Antibody Revenue in 2024
 Figure 18. North America Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Bispecific and Trispecific Antibody Market Share by Country (2020-2031)
 Figure 20. United States Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Bispecific and Trispecific Antibody Market Share by Country (2020-2031)
 Figure 24. Germany Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Bispecific and Trispecific Antibody Market Share by Region (2020-2031)
 Figure 32. China Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Bispecific and Trispecific Antibody Market Share by Country (2020-2031)
 Figure 40. Mexico Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Bispecific and Trispecific Antibody Market Share by Country (2020-2031)
 Figure 44. Turkey Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Bispecific and Trispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. AbbVie Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 48. Affimed Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 49. Biotheus Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 50. Biontech Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 51. Genmab Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 52. GT Biopharma Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 53. Harpoon Therapeutics Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 54. MacroGenics Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 55. Numab Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 56. Sanofi Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 57. Sichuan Baili Pharmaceuticals Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 58. Roche Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 59. Amgen Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 60. Pfizer Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 61. Johnson & Johnson Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 62. AstraZeneca Revenue Growth Rate in Bispecific and Trispecific Antibody Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

BiSpecific MAbS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Antibody Technology Platform Market Research Report 2025
Bispecific Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CD Targeted Bispecific Antibody Market Research Report 2024
Global Bispecific Antibodies Drug Market Research Report 2025
Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030
Global T Cell NK Cell Engaging Bispecific Antibodies Market Research Report 2025
Global Chimeric Antibody Market Research Report 2025
Global Antibodies Market Research Report 2024
Recombinant Antibody Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Secondary Antibodies Market Research Report 2025
Global Bispecific Antibody Development Platform Market Research Report 2024
Global Bi Specific MAbS Market Research Report 2024
Global Secondary Antibody Market Research Report 2024
Antibody Sequencing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Integrin Beta3 Antibody Market Research Report 2024
Fully Humanized Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Double Barreled Antibodies Drug Market Research Report 2025
Global Ready to Use Antibodies Market Research Report 2025
Global Bispecific Antibody Molecular Drug Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions